New York Life Trust’s VeriSign VRSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$8K Sell
97
-1,156
-92% -$96K 0.39% 89
2016
Q4
$95K Buy
1,253
+921
+277% +$72.8K 0.45% 91
2016
Q3
$26K Sell
332
-633
-66% -$50.8K 0.13% 171
2016
Q2
$83K Sell
965
-110
-10% -$9.48K 0.4% 94
2016
Q1
$95K Sell
1,075
-148
-12% -$12.1K 0.41% 85
2015
Q4
$107K Sell
1,223
-305
-20% -$25.4K 0.46% 81
2015
Q3
$108K Buy
1,528
+546
+56% +$37.2K 0.48% 78
2015
Q2
$61K Sell
982
-925
-49% -$59.6K 0.25% 130
2015
Q1
$128K Sell
1,907
-153
-7% -$9.3K 0.51% 73
2014
Q4
$117K Sell
2,060
-34
-2% -$1.96K 0.46% 89
2014
Q3
$115K Buy
2,094
+38
+2% +$2.05K 0.48% 89
2014
Q2
$100K Buy
2,056
+113
+6% +$5.63K 0.42% 108
2014
Q1
$105K Buy
1,943
+155
+9% +$8.77K 0.46% 91
2013
Q4
$107K Sell
1,788
-193
-10% -$10.6K 0.49% 81
2013
Q3
$101K Sell
1,981
-323
-14% -$15.6K 0.51% 74
2013
Q2
$103K Buy
+2,304
New +$107K 0.47% 81

Other funds holding VRSN

New York Life Trust's VRSN Position: Q1 2017 in Review

New York Life Trust reduced its VeriSign (VRSN) stake by 92% in Q1 2017, selling an estimated $96K and leaving 97 shares worth $8K. The position accounts for 0.39% of the portfolio, ranked #89.

New York Life Trust first reported a position in VRSN in Q2 2013 and has held it in 16 quarters since. The position peaked at $128K in Q1 2015. 395 funds tracked by Wall St. Rank hold VRSN as of Q1 2017.

  • New York Life Trust held 97 shares of VeriSign worth $8K as of Q1 2017.
  • New York Life Trust sold 1,156 VeriSign shares in Q1 2017, an estimated $96K.
  • VeriSign made up 0.39% of New York Life Trust's portfolio in Q1 2017, its #89 holding.
  • New York Life Trust first reported a position in VeriSign in Q2 2013 and has held it in 16 quarters since.
  • New York Life Trust's VeriSign position peaked at $128K in Q1 2015.
  • 395 funds tracked by Wall St. Rank held VeriSign as of Q1 2017.

Based on New York Life Trust's 13F filing for Q1 2017, filed 12 May 2017.